Yongyong MA

1 clinical trials · Sponsor

Record	Firm	Date
Daratumumab/Daratumumab and Hyaluronidase-fihj in Combination With Pomalidomide and Dexamethasone for the Treatment of Patients With Newly Diagnosed AL Amyloidosis: a Prospective, Multicenter, Single-arm Study (NCT06455748)	Yongyong MA	2024-03-01

Every clearance here is in the API, with alerts when new ones post.